Molecular modeling and dynamic simulation of chicken Mx protein with the S631N polymorphism

Vijayakumar Gosu1, Donghyun Shin2,3, Ki-Duk Song1,2,3

  • 1Department of Animal Biotechnology, Jeonbuk National University, Jeonju, Republic of Korea.

Insights

Computational analysis reveals structural and dynamic differences between wild-type and S631N mutant chicken Mx (chMx) proteins. These findings may explain the antiviral activity of the chMx S631N variant.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Virology

Background:

  • Myxovirus resistance (Mx) proteins are key antiviral GTPases induced by type I interferons (IFNs).
  • A specific variant, S631N, in chicken Mx (chMx) protein is hypothesized to confer antiviral properties.
  • The structural and conformational impact of the S631N mutation on chMx remains uncharacterized.

Purpose of the Study:

  • To investigate the structural and dynamic behavior of wild-type and S631N mutant chMx proteins using computational methods.
  • To elucidate how the S631N mutation affects chMx protein structure and conformation.
  • To identify key residues involved in intramolecular signaling within chMx.

Main Methods:

  • 3D structural modeling of wild-type and mutant chMx proteins.
  • Molecular dynamics (MD) simulations to analyze protein dynamics.
  • Inter-domain motion analysis.
  • Residue network analysis (betweenness centrality) to identify crucial residues.

Main Results:

  • 3D models showed chMx shares structural similarity with human Mx proteins.
  • MD simulations indicated altered hinge1 region dynamics and distinct stalk domain conformations between wild-type and mutant chMx.
  • Conformational changes in a loop region near the S631N mutation likely cause an inclined stalk domain in the mutant.
  • Residue network analysis identified critical residues for intramolecular signal transmission.

Conclusions:

  • This study provides novel insights into the structural and dynamic differences between wild-type and S631N mutant chMx proteins.
  • The identified structural variations may underlie the enhanced antiviral activity associated with the chMx S631N variant.
  • Understanding these molecular differences can inform future strategies for developing antiviral therapies.